{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:34:35Z","timestamp":1794940475956,"version":"4.9.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,16]]},"abstract":"<jats:p>\n                    The role of albumin in Parkinson disease (PD) is not well understood, our study will investigate the association between the serum albumin level and risk of dementia, motor impairment, as well as survival outcome in PD. Data were obtained from the publicly available dataset in the DRYAD database (https:\/\/datadryad.org\/). The original prospective study enrolled patients with PD from a single center in Japan between March 2004 and November 2007. Due to missing values, 242 and 274 participants were included in the study, in which we aimed to, respectively, analyze the relationship between serum albumin and cognitive function as well as motor impairment; additionally, 264 participants were included to assess the association between baseline serum albumin levels and risk of PD-related death with a median follow-up of 5.24 years. Compared to patients of the low tertile of albumin levels, Mini-Mental State Examination (MMSE) of patients of middle tertile increased 2.09 [95% confidence interval (CI) (0.45, 3.73),\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = .013], independent of age, sex, PD duration, modified Hoehn-Yahr (mHY) stage, C-reactive protein (CRP) level, and use of nonsteroidal anti-inflammatory drugs (NSAIDs). Further analysis revealed a positive curvilinear association between albumin and MMSE, with cutoff values of 3.9. As concentration serum albumin increased, the risk of severe motor impairment was grown [odds ratio (OR) 0.34 (95% CI 0.14,0.8),\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = .013] after adjustment by age, sex, PD duration, MMSE scores, CRP level, and use of NSAIDs. Albumin levels increased per unit of mg\/dL, and the risk of PD-related death reduced 0.74-fold with 95% CI (0.15, 0.86) (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = .021), independent of age, sex, PD disease duration, mHY stage, CRP levels, use of NSAIDs, and MMSE. Higher serum albumin levels were significantly association with the better cognitive function when albumin was &lt;3.9 mg\/dL, and played a protective role in severe motor impairment and PD-related death.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000030324","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T09:25:37Z","timestamp":1663579537000},"page":"e30324","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3326-2632","authenticated-orcid":false,"given":"Shujun","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Neurology, The Frist People\u2019s Hospital of Changde City, Changde, Hunan 415003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyong","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of General Practice, The Frist People\u2019s Hospital of Changde City, Changde, Hunan 415003, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Frist People\u2019s Hospital of Changde City, Changde, Hunan 415003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mds.25292","article-title":"The current and projected economic burden of Parkinson\u2019s disease in the United States.","volume":"28","author":"Kowal","year":"2013","journal-title":"Mov Disord: Off J Mov Disord Soc"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","article-title":"Cost of disorders of the brain in Europe 2010.","volume":"21","author":"Gustavsson","year":"2011","journal-title":"Eur Neuropsychopharmacol: J Eur College Neuropsychopharmacol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1474-4422(19)30195-4","article-title":"Parkinson\u2019s disease in the western pacific region.","volume":"18","author":"Lim","year":"2019","journal-title":"Lancet Neurol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1515\/rns.2011.028","article-title":"Current perspectives on potential role of albumin in neuroprotection.","volume":"22","author":"Prajapati","year":"2011","journal-title":"Rev Neurosci"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1212\/WNL.0000000000010005","article-title":"Serum albumin and beta-amyloid deposition in the human brain.","volume":"95","author":"Kim","year":"2020","journal-title":"Neurology"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s12877-020-01789-0","article-title":"Effects of kidney function, serum albumin and hemoglobin on dementia severity in the oldest old people with newly diagnosed Alzheimer\u2019s disease in a residential aged care facility: a cross-sectional study.","volume":"20","author":"Wu","year":"2020","journal-title":"BMC Geriatr"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/JAD-160565","article-title":"Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-\u03b2 concentrations and cognition outcomes in Alzheimer\u2019s disease patients: a multicenter, randomized, controlled clinical trial.","volume":"56","author":"Boada","year":"2017","journal-title":"J Alzheimer\u2019s Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies.","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1021\/acs.jpcb.9b02381","article-title":"Dissecting the interactions between human serum albumin and \u03b1-synuclein: new insights on the factors influencing \u03b1-synuclein aggregation in biological fluids.","volume":"123","author":"Bellomo","year":"2019","journal-title":"J Phys Chem B"},{"key":"R10-20250504","first-page":"9686","article-title":"Molecular mechanism for the suppression of alpha synuclein membrane toxicity by an unconventional extracellular chaperone.","volume":"142","author":"Ahmed","year":"2020","journal-title":"J Am Chem Soc"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"e0134118","DOI":"10.1371\/journal.pone.0134118","article-title":"Baseline C-reactive protein levels and life prognosis in Parkinson disease.","volume":"10","author":"Hashimoto","year":"2015","journal-title":"PLoS One"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"d198","DOI":"10.1136\/bmj.d198","article-title":"Use of non-steroidal anti-inflammatory drugs and risk of Parkinson\u2019s disease: nested case-control study.","volume":"342","author":"Driver","year":"2011","journal-title":"BMJ (Clinical research ed)"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1600-0404.1986.tb07863.x","article-title":"Serum amyloid A protein, albumin and prealbumin in Alzheimer\u2019s disease and in demented patients with Down\u2019s syndrome.","volume":"74","author":"Elovaara","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/gps.1469","article-title":"Decreased plasma antioxidants in patients with Alzheimer\u2019s disease.","volume":"21","author":"Kim","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.jrn.2007.12.003","article-title":"Hypoalbuminemia and not hyperhomocysteinemia as a risk factor for dementia in hemodialysis patients.","volume":"18","author":"Huang","year":"2008","journal-title":"J Ren Nut"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1111\/j.1572-0241.2001.04099.x","article-title":"Percutaneous endoscopic gastrostomy and outcome in dementia.","volume":"96","author":"Dharmarajan","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10072-016-2738-z","article-title":"Impact of serum uric acid, albumin and their interaction on Parkinson\u2019s disease.","volume":"38","author":"Wang","year":"2017","journal-title":"Neurol Sci"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"533731","DOI":"10.3389\/fneur.2020.533731","article-title":"Prevalence and risk factors for malnutrition in patients with Parkinson\u2019s disease.","volume":"11","author":"Yang","year":"2020","journal-title":"Front Neurol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ypmed.2018.04.015","article-title":"Albumin levels and cause-specific mortality in community-dwelling older adults.","volume":"112","author":"Wu","year":"2018","journal-title":"Prev Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease.","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann Neurol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12035-013-8483-x","article-title":"The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson\u2019s disease: focus on astrocytes.","volume":"49","author":"Niranjan","year":"2014","journal-title":"Mol Neurobiol"},{"issue":"Pt B","key":"R22-20250504","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease.","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol Dis"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bbamem.2018.01.015","article-title":"Serum albumin impedes the amyloid aggregation and hemolysis of human islet amyloid polypeptide and alpha synuclein.","volume":"1860","author":"Kakinen","year":"2018","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"R24-20250504","first-page":"966","article-title":"The universal soldier: enzymatic and non-enzymatic antioxidant functions of serum albumin.","volume":"9","author":"Belinskaia","year":"2020","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/acn3.50990","article-title":"Nonmercaptalbumin as an oxidative stress marker in Parkinson\u2019s and PARK2 disease.","volume":"7","author":"Ueno","year":"2020","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:44:54Z","timestamp":1746319494000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":25,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030324","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]}}}